Gastric adenocarcinoma is a type of cancer that forms in the cells of the stomach lining. It is the most common type of stomach cancer and is the fourth leading cause of cancer death in the world. Symptoms of gastric adenocarcinoma can include abdominal pain, nausea, vomiting, loss of appetite, and weight loss. If the cancer has spread, patients may also experience fatigue, difficulty swallowing, and blood in their stool. Diagnosis of gastric adenocarcinoma typically involves a physical examination, imaging studies such as CT or MRI, and endoscopic procedures. Treatment choices depend on the stage of the cancer and can include surgery, chemotherapy, and/or radiation. Surgery is often the most effective way to remove the cancer and is usually combined with chemotherapy and/or radiation. For those with advanced gastric adenocarcinoma, palliative care may be an option. Palliative care focuses on providing relief from symptoms and improving quality of life, rather than attempting to cure the cancer. This may include medications to reduce pain and nausea, nutritional support, and psychological support.
Title : Gastroenterology viewed through a glass darkly: An IDI perspective
Gilles R G Monif, University of Florida, United States
Title : The psychology of disorders of gut-brain interactions
Tracy E Hill, Ph.D. & Associates LLC, United States
Title : How epigastric impedance would radically change gastric medicine
John Andrew Sutton, Gastria Ltd, United Kingdom
Title : Role of Pregnancy (P) and breastfeeding on Gallstones (GS) related Acute Pancreatitis (AP)
Alberto Maringhini, La Maddalena, Italy
Title : From the birth of atoms to life: Iodine and caesium, angels and demons of evolutionary biology, in pancreatic cancer and diabetes
Venturi Sebastiano, AUSL-ROMAGNA, Italy
Title : The IL17REL gene encodes a decoy receptor of IL-17 family cytokines to control gut inflammation
Youcun Qian, Shanghai Institute of Nutrition and Health, China